𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene-deficient mice

✍ Scribed by Almholt, Kasper; Nielsen, Boye S; Frandsen, Thomas L; Brünner, Nils; Danø, Keld; Johnsen, Morten

Book ID
110067698
Publisher
Nature Publishing Group
Year
2003
Tongue
English
Weight
273 KB
Volume
22
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Unimpeded skin carcinogenesis in K14-HPV
Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor
✍ Anne Masset; Catherine Maillard; Nor Eddine Sounni; Nathalie Jacobs; Françoise B 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 683 KB

## Abstract Angiogenesis, extracellular matrix remodeling and cell migration are associated with cancer progression and involve at least, the plasminogen activating system and its main physiological inhibitor, the plasminogen activator inhibitor‐1 (PAI‐1). Considering the recognized importance of P

Immunohistochemical localization of the
Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer
✍ Elisabetta Bianchi; Robert L. Cohen; Aihua Dai; Ann T. Thor; Marc A. Shuman; Hel 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 848 KB

We used an immunohistochemical assay with an antigenretrieval technique to study plasminogen activator inhibitor type-I (PAL I) expression in paraffin-embedded breast tissue samples at different stages of malignant transformation. We detected PAI-I in 15/20 invasive tumors. In several cases staining

Reduced metastasis of transgenic mammary
Reduced metastasis of transgenic mammary cancer in urokinase-deficient mice
✍ Kasper Almholt; Leif R. Lund; Jørgen Rygaard; Boye S. Nielsen; Keld Danø; John R 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 232 KB

A prominent phenotype of plasmin deficiency in mice is reduced metastasis in the MMTV-PymT transgenic breast cancer model. Proteolytically active plasmin is generated from inactive plasminogen by one of 2 activators, uPA or tPA. We now find that uPA deficiency alone significantly reduces metastasis